Search Results - "Dillard, Clémentine"
-
1
Colorectal Cancer and Immunity: From the Wet Lab to Individuals
Published in Cancers (04-04-2021)“…Immunotherapy is a very promising field of research and application for treating cancers, in particular for those that are resistant to chemotherapeutics…”
Get full text
Journal Article -
2
Expression Pattern of Purinergic Signaling Components in Colorectal Cancer Cells and Differential Cellular Outcomes Induced by Extracellular ATP and Adenosine
Published in International journal of molecular sciences (25-10-2021)“…The purine nucleotide adenosine triphosphate (ATP) is known for its fundamental role in cellular bioenergetics. However, in the last decades, different works…”
Get full text
Journal Article -
3
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53
Published in Blood (21-11-2019)“…B-cell prolymphocytic leukemia (B-PLL) is a rare hematological disorder whose underlying oncogenic mechanisms are poorly understood. Our cytogenetic and…”
Get full text
Journal Article -
4
The C-Terminal Acidic Tail Modulates the Anticancer Properties of HMGB1
Published in International journal of molecular sciences (17-07-2022)“…Energy metabolism reprogramming was recently listed as a hallmark of cancer. In this process, the switch from pyruvate kinase isoenzyme type M1 to pyruvate…”
Get full text
Journal Article -
5
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53
Published in Blood (16-09-2019)“…Key Points B-PLL is tightly linked to MYC aberrations (translocation or gain) and 17p (TP53) deletion. Cases of B-PLL with MYC aberration and 17p (TP53)…”
Get full text
Journal Article -
6
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53
Published in Blood (16-09-2019)“…Key Points B-PLL is tightly linked to MYC aberrations (translocation or gain) and 17p (TP53) deletion. Cases of B-PLL with MYC aberration and 17p (TP53)…”
Get full text
Journal Article -
7
Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group
Published in Blood (29-11-2018)“…B-PLL is defined by the presence of prolymphocytes in peripheral blood exceeding 55% of lymphoid cells. The diagnosis, mainly based on clinical and…”
Get full text
Journal Article